重新定位的 prokaryotic 集群定期间隔的短 palindromic 重复-Cas 适应性免疫系统来对抗抗菌素耐药性
Veena Devi1, Kusum Harjai1, Sanjay Chhibber1
1Department of Microbiology, Panjab University, Chandigarh, 160014, India.
Future microbiology
|June 15, 2023
概括
新的集群定期间隔的简短巴林德罗姆重复 (CRISPR-Cas) 疗法为对抗抗生素耐药性感染提供了有前途的解决方案. 研究重点是开发CRISPR-Cas抗微生物药物和解决它们的交付挑战,以打击多药性耐药性.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
背景情况:
- 全球卫生面临传染病的威胁越来越大,特别是那些由抗生素耐药微生物引起的.
- 滥用抗生素加快了多药性耐药性的增加,迫切需要新的抗菌策略.
研究的目的:
- 审查集群定期间隔的短时间Palindromic重复 (CRISPR) -Cas作为一种新型抗菌疗法的发展.
- 探索利用CRISPR-Cas系统打击抗生素耐药性的策略,包括消除病原体和恢复抗生素敏感性.
主要方法:
- 关于CRISPR-Cas抗菌药物开发的当前研究的文献综述.
- 对针对多抗药性病原体的不同基于CRISPR-Cas的策略进行分析.
- 检查与CRISPR-Cas抗菌剂的交付相关的挑战.
主要成果:
- 克里斯普尔-卡斯基因编辑技术显示出作为一种替代抗菌治疗方法的巨大潜力.
- 研究人员正在积极探索消除致病菌株或使用CRISPR-Cas.重新敏感化它们对现有抗生素的方法.
- 针对细菌的CRISPR-Cas系统的交付仍然是临床应用的关键挑战.
结论:
- 克里斯普尔-卡斯抗菌剂在打击抗生素耐药性的斗争中是一个有希望的前沿.
- 进一步的研究和开发对于克服交付障碍和将CRISPR-Cas技术转化为有效的临床治疗至关重要.
- 克里斯珀-Cas的战略应用有可能缓解多药耐药性感染带来的全球健康危机.
更多相关视频
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
7.9K
08:20A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
4.2K
相关概念视频
CRISPR/Cas9 Genome Editing
78
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
78
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
CRISPR
52.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.5K
The Antiviral System of Bacteria and Archaea: CRISPR
62
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
62
Homologous Recombination
50.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.7K
Antibiotic Selection
54.8K
Overview
54.8K
